Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the jetpack-backup domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/vgbdoo6u2d7y/public_html/mcmillanresearch.com/wp-includes/functions.php on line 6121
Horrendous Rise in Liver Disease - Any Idea of the Cause? - McMillan Research Limited
Select Page

Horrendous Rise in Liver Disease – Any Idea of the Cause?

May 25, 2024 | COVID-19, Research, Treatment

Responsive Centered YouTube Video
Analysis of rising liver disease cases and reluctance to address underlying issues.

  • Focus on autoimmunity in severe COVID-19 cases triggering immune system to attack itself. • 0:11

  • Upcoming webinar on potential mechanisms of rising liver disease, with free and donation-based tickets available. • 1:04

  • Importance of addressing ‘elephant in the room’ to properly manage crises and challenges. • 1:34

  • Observation of reluctance by politicians and industry to address critical issues affecting society. • 2:05

  • Reference to data analysis on excess mortality causes in England by outside Allen. • 2:23

Alarming increase in liver disease mortality rates analyzed by condition and timeline.

  • Breakdown of excess mortality by condition and percentage above normal • 3:11

  • Color-coded representation of mortality rates based on percentage deviation • 3:33

  • Analysis of data from March 2020 to December 2023 • 4:07

  • Identification of key conditions contributing to high mortality rates • 4:40

  • Notable increase in mortality due to heart failure and ischemic heart disease • 5:03

  • Unexpected rise in mortality related to cirrhosis highlighted in the data • 5:20

Elevated liver disease rates observed from late 2022 to 2023, with a focus on understanding disease mechanisms and impacts on patients.

  • Liver disease rates remained high, exceeding 20% above baseline in June 2023. • 6:14

  • Liver diseases such as hepatitis, cirrhosis, and liver cancer are significant health concerns. • 7:31

  • Autoimmune liver diseases and their potential connection to SARS-CoV-2 are being researched. • 9:01

Autoimmunity in liver disease possibly linked to SARS-CoV-2 infection and vaccination.

  • Autoimmunity can be triggered by severe acute respiratory syndrome coronavirus 2. • 9:19

  • Patients with autoimmune liver disease may not have increased risk of SARS-CoV-2 infection. • 10:16

  • SARS-CoV-2 infection may lead to the development of autoimmune diseases, including autoimmune hepatitis. • 10:30

  • Reports suggest a possible association between SARS-CoV-2 vaccines and autoimmune hepatitis. • 11:24

  • Liver disease with autoimmunity can go undetected until significant damage is present. • 12:02

  • Combining infection and vaccination may lead to a heightened immune response. • 12:17

Risk of autoimmune responses in liver disease due to immune priming and infection.

  • Liver under stress may have reduced threshold for damage. • 12:54

  • Advice on alcohol consumption and liver health. • 13:24

  • Combining infection and liver stress increases risk of disease. • 13:41

  • Importance of not underestimating the effects of combined factors. • 13:52

  • Circulating virus can trigger autoimmunity and damage. • 14:14

  • Research needed to understand impact and mitigation strategies. • 14:20

  • Join event on February 29 for more information. • 14:31